|
| |
| | | 69305 | | 31.01.2025 | | Mepha Pharma AG | | | | | | | 30.01.2030 | | | | | | | | | | 06.03. | | |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Rivaroxaban-Mepha 10 mg | Hartkapseln | Capsules (Rivaroxabanum 10 mg) | B01AF01 | | | 02 | Rivaroxaban-Mepha 15 mg | Hartkapseln | Capsules (Rivaroxabanum 15 mg) | B01AF01 | | | 03 | Rivaroxaban-Mepha 20 mg | Hartkapseln | Capsules (Rivaroxabanum 20 mg) | B01AF01 | |
|
|
|
